neuropeptide Y-(3-36)



neuropeptide Y-(3-36)

S1SS1K2KK2P3PP3D4DD4N5NN5P6PP6G7GG7E8EE8D9DD9A10AA10P11PP11A12AA12E13EE13D14DD14M15MM15A16AA16R17RR17Y18YY18Y19YY19S20SS20A21AA21L22LL22R23RR23H24HH24Y25YY25I26II26N27NN27L28LL28I29II29T30TT30R31RR31Q32QQ32R33RR33Y34YY34

SMILES None
InChIKey None
Sequence SKPDNPGEDAPAEDMARYYSALRHYINLITRQRY

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections


No bioactivity data available.

neuropeptide Y-(3-36)

S1SS1K2KK2P3PP3D4DD4N5NN5P6PP6G7GG7E8EE8D9DD9A10AA10P11PP11A12AA12E13EE13D14DD14M15MM15A16AA16R17RR17Y18YY18Y19YY19S20SS20A21AA21L22LL22R23RR23H24HH24Y25YY25I26II26N27NN27L28LL28I29II29T30TT30R31RR31Q32QQ32R33RR33Y34YY34

Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections


Compound is not listed as a drug.